2019-11-15T14:23:39-06:00 2018-12-31 410746749 CLIFTONLARSONALLEN LLP 901 N GLEBE ROAD SUITE 200 ARLINGTON VA 22203 990 2018-01-01 521224577 BIOTECHNOLOGY INNOVATION ORGANIZATION BIOT 2029629200 1201 MARYLAND AVENUE SW NO 900 WASHINGTON DC 20024 YVETTE WHITE-WIGGINS CFO AND SVP, FINANCE & ADMIN 2029629200 2019-11-15 1 AMY CHAPMAN P00843460 5712279500 67.137.57.251 2019-11-15 15:22:47 ES P 3F26782FE4A8D097B8E6D44DA42E2066FBD559CC 2133D0EBAFB53FCF2392F5AD4E899C8767C52AD0 2018 2020-04-17 16:48:07Z JAMES C GREENWOOD 1201 MARYLAND AVENUE SW NO 900 WASHINGTON DC 20024 87471231 0 X WWW.BIO.ORG X 1993 DC SUPPORT THE BIOTECHNOLOGY INDUSTRY TO EXPAND THE BOUNDARIES OF SCIENCE TO BENEFIT MANKIND. 138 138 218 148 693008 0 0 0 66032153 72848062 2716705 2538802 9803104 11923567 78551962 87310431 785500 2626800 0 0 34575243 36867200 0 0 0 42956281 47030501 78317024 86524501 234938 785930 81025145 78940053 34368598 36968656 46656547 41971397 X THE BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) REPRESENTS APPROXIMATELY 1,000 COMPANIES AND ORGANIZATIONS IN WASHINGTON DC, STATE CAPITALS, AND INTERNATIONAL FORA. BIO IS FOUNDED ON THE PRINCIPLE THAT POLICY MUST NURTURE INNOVATION IN THE LIFE SCIENCES TO OVERCOME CHALLENGES IN HEALTH CARE, AGRICULTURE, INDUSTRY, AND THE ENVIRONMENT. OUR MEMBERS REPRESENT COMPANIES OFFERING A SPECTRUM OF BIOTECHNOLOGY APPLICATIONS ACROSS MAJOR SECTORS OF THE ECONOMY. BIO MEMBERS ALSO INCLUDE UNIVERSITIES, NONPROFITS, PATIENT GROUPS, AND OTHER ORGANIZATIONS THAT PLAY AN IMPORTANT ROLE IN THE FUTURE OF THE LIFE SCIENCES. BIO'S ACTIVITIES ARE BROKEN DOWN INTO TWO PROGRAMS - ADVOCACY AND SERVICES. 0 0 ADVOCACY: BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)'S ADVOCACY EFFORTS REFLECT THE PRIORITIES IDENTIFIED BY THE BIO BOARD OF DIRECTORS AND THE FOUR SECTION GOVERNING BOARDS.THE BOARD OF DIRECTORS FOCUSES ON ISSUES OF IMPORTANCE TO ALL BIO MEMBERS, REGARDLESS OF THEIR SIZE OR TECHNOLOGY. THESE CROSS-CUTTING ADVOCACY ACCOMPLISHMENTS IN 2017 ARE LISTED BELOW: - SAFEGUARDED AND ADVANCED INTELLECTUAL PROPERTY PROTECTIONS, DOMESTICALLY AND INTERNATIONALLY.- FOSTERED A DIALOGUE ABOUT BIOETHICS AND PROACTIVELY ADVANCED THE SOCIALLY RESPONSIBLE USE OF BIOTECHNOLOGY.- PROMOTED INVESTMENT IN GOVERNMENT AND ACADEMIC RESEARCH.- EXPANDED OUTREACH TO FOREIGN GOVERNMENTS AND INTERNATIONAL ENTITIES TO EDUCATE ON POLICY ISSUES OF IMPORTANCE TO THE BIOTECHNOLOGY INDUSTRY AND TO IMPROVE THE INVESTMENT AND REGULATORY CLIMATE FOR BIOTECH PRODUCTS.THE HEALTH SECTION 2018 ADVOCACY ACCOMPLISHMENTS: - PROMOTED HEALTHCARE POLICIES THAT RECOGNIZE BOTH THE PROMISE AND VALUE OF INNOVATION.- ADVOCATED FOR A SAFE AND PREDICTABLE REGULATORY ENVIRONMENT FOR VALUE-BASED PAYMENT ARRANGEMENTS FOR DRUGS AND BIOLOGICS.- ENHANCED AND PROTECTED PATIENT ACCESS TO INNOVATIVE THERAPIES AND PROMOTED THE NEED FOR GREATER NONDISCRIMINATION ENFORCEMENT AGAINST INSURANCE BENEFIT DESIGNS.- ADVOCATED FOR BIOSIMILARS POLICIES THAT PROTECT PATIENT SAFETY, PROMOTE BIOMEDICAL INNOVATION, AND ADVANCE THE SCIENCE-BASED REVIEW AND APPROVAL OF BIOSIMILARS AND INTERCHANGEABLE BIOLOGICAL PRODUCTS.- PROMOTED THE VALUE OF U.S. GOVERNMENT INVESTMENTS IN PROGRAMS THAT IMPROVE ACCESS TO IMMUNIZATIONS AND FOSTER VACCINE INNOVATION, STRENGTHENED OUR ABILITY TO RESPOND TO BIOTERROR THREATS OR EMERGING INFECTIOUS DISEASES, AND ENCOURAGED DEVELOPMENT OF NEW PRODUCTS TO FIGHT ANTIMICROBIAL RESISTANCE (AMR).- INFLUENCED IMPROVEMENTS TO THE INTERNATIONAL ENVIRONMENT FOR BIOMEDICAL INNOVATION AND GLOBAL PUBLIC HEALTH PREPAREDNESS.THE EMERGING COMPANIES SECTION 2018 ADVOCACY ACCOMPLISHMENTS: - ADVANCED THE INTEREST OF EMERGING COMPANIES IN CAPITAL FORMATION AND FINANCIAL SERVICES POLICY.- ADVOCATED FOR TAX POLICIES SUPPORTING INNOVATIVE EMERGING COMPANIES AND INVESTMENT IN GROUNDBREAKING R&D; ENHANCED THE VOICE OF PRE-REVENUE, R&D-INTENSIVE BUSINESSES IN THE TAX REFORM DEBATE.- ADVOCATED FOR THE REMOVAL OF BURDENSOME FINANCIAL REPORTING REGULATIONS ON EMERGING COMPANIES.THE FOOD & AGRICULTURE SECTION 2018 ADVOCACY ACCOMPLISHMENTS: - WORKED WITH THE ADMINISTRATION AND CONGRESS TO ADVANCE IMPROVEMENTS TO THE U.S. AND GLOBAL REGULATORY SYSTEMS FOR AG-BIOTECH PRODUCTS. - WORKED WITH MEMBERS OF THE AGRICULTURAL VALUE CHAIN TO ADDRESS TRADE ISSUES IN AGRICULTURAL EXPORT MARKETS SUCH AS CHINA AND EUROPE. - ADVOCATED IN LEGISLATURES AND COURTS TO PRESERVE THE RIGHTS OF FARMERS TO PLANT GENETICALLY ENGINEERED CROPS. THE INDUSTRIAL & ENVIRONMENTAL SECTION 2018 ADVOCACY ACCOMPLISHMENTS: - SUPPORTED A RENEWABLE CHEMICALS REPORT.- ADVOCATED FOR EPA TO TREAT ALL SUSTAINABLY SOURCED BIOMASS AS ELIGIBLE MEASURES FOR EMISSIONS REDUCTION CREDIT (ERC) GENERATION. - ADVOCATED REGARDING THE IMPLEMENTATION OF THE TOXIC SUBSTANCES CONTROL ACT (TSCA) AS AMENDED BY CONGRESS, AS WELL AS ISSUES RELATING TO THE NATIONAL BIOENGINEERED FOOD DISCLOSURE ACT.- ENGAGED WITH THE ADMINISTRATION'S REVIEW OF THE COORDINATED FRAMEWORK FOR BIOTECHNOLOGY, INCLUDING WITH RESPECT TO THE REGULATION OF GENETICALLY ENGINEERED (GE) ALGAE.- URGED CONGRESS TO EXTEND A SUITE OF CRITICAL ADVANCED BIOFUELS TAX INCENTIVES BEYOND 2017. SERVICES: BIO'S SERVICES INCLUDE CONFERENCES AND ACTIVITIES THAT BRING TOGETHER INDUSTRY STAKEHOLDERS AND INVESTORS FOR EVENTS RANGING FROM THE BIO INTERNATIONAL CONVENTION TO CONFERENCES FOR BUSINESS DEVELOPMENT EXECUTIVES. THE BIO INTERNATIONAL CONVENTION ATTRACTS APPROXIMATELY 16,000 OF THE MOST INFLUENTIAL BIOTECH AND PHARMA ATTENDEES FROM 76 COUNTRIES AND 48 U.S. STATES, AS WELL AS THE DISTRICT OF COLUMBIA, PUERTO RICO AND THE US VIRGIN ISLANDS, INCLUDING 300 MEMBERS OF THE MEDIA, AND OFFERS THREE DAYS OF PROFESSIONAL AND BUSINESS DEVELOPMENT OPPORTUNITIES. THE NET INCOME FROM THE CONVENTION SUPPORTS OUR ADVOCACY, PUBLIC OUTREACH, AND OTHER MEMBER SERVICE ACTIVITIES. THE KEY ELEMENTS OF THE BIO INTERNATIONAL CONVENTION ARE EDUCATIONAL PROGRAMMING, EXHIBITION, THE BIO BUSINESS FORUM, AND NETWORKING EVENTS. THESE ELEMENTS PROVIDE AN OPPORTUNITY FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, ACADEMIC RESEARCH INSTITUTIONS, AND INVESTORS FROM AROUND THE WORLD TO LEARN ABOUT RECENT SCIENTIFIC AND POLICY DEVELOPMENTS, AND SCHEDULE ONE-ON-ONE MEETINGS TO DISCUSS POTENTIAL BUSINESS OPPORTUNITIES. THE BIO BUSINESS FORUM AT THE CONVENTION HOSTS TENS OF THOUSANDS OF PARTNERING MEETINGS AMONG A FEW THOUSAND COMPANIES, ALONG WITH A COUPLE HUNDRED COMPANY PRESENTATIONS. THE CONVENTION HOSTS HUNDREDS OF SPEAKERS, AND OVER A THOUSAND EXHIBITIONS WITH INTERNATIONAL, REGIONAL AND STATE PAVILIONS (AND A NUMBER OF PRODUCT FOCUS ZONES).BEYOND THE CONVENTION, BIO HOSTS OR CO-HOSTS A NUMBER OF NATIONAL AND INTERNATIONAL CONFERENCES THAT PROVIDE VENUES FOR MEMBER AND NON-MEMBER COMPANIES TO PRESENT NEW DATA, MEET WITH FELLOW BIOTECH COMPANIES, AND ATTRACT FUNDING FROM INVESTORS AND OTHER ORGANIZATIONS. 0 0 0 1 0 0 0 0 0 1 0 0 0 1 0 1 0 0 0 1 1 0 0 0 0 0 1 0 1 0 0 0 0 1 0 0 0 0 0 0 1 0 0 1 177 0 218 1 1 1 1 IN 0 0 0 0 1 0 X 138 138 0 0 0 0 1 1 0 1 1 0 0 0 1 1 1 1 1 1 1 0 X YVETTE WHITE-WIGGINS 2029629200 1201 MARYLAND AVENUE SW SUITE 990 WASHINGTON DC 20024 JOHN MARAGANORE CHAIR 2.00 X X 0 0 0 RON COHEN IMMEDIATE PAST CHAIR 2.00 X X 0 0 0 BRADFORD ZAKES TREASURER 2.00 X X 0 0 0 JULIE GERBERDING SECRETARY 2.00 X X 0 0 0 ABBIE CELNIKER DIRECTOR 2.00 X 0 0 0 ADAM MONROE DIRECTOR 2.00 X 0 0 0 ADELENE PERKINS DIRECTOR 2.00 X 0 0 0 ALAN SHAW DIRECTOR 2.00 X 0 0 0 ALBERT BOURLA DIRECTOR 2.00 X 0 0 0 AMIR NASHAT DIRECTOR 2.00 X 0 0 0 ANNA PROTOPAPAS DIRECTOR 2.00 X 0 0 0 ANNA RATH DIRECTOR 2.00 X 0 0 0 ANNE PHILLIPS DIRECTOR 2.00 X 0 0 0 BARRY FLANNELLY DIRECTOR 2.00 X 0 0 0 BASSIL DAHIYAT DIRECTOR 2.00 X 0 0 0 BENJAMIN KNUDSEN DIRECTOR 2.00 X 0 0 0 BILL ANDERSON DIRECTOR 2.00 X 0 0 0 BILL CAMPBELL DIRECTOR 2.00 X 0 0 0 BILL SIBOLD DIRECTOR 2.00 X 0 0 0 BOB MORE DIRECTOR 2.00 X 0 0 0 BOB WALSH DIRECTOR 2.00 X 0 0 0 BRIAN PEREIRA DIRECTOR 2.00 X 0 0 0 BRIAN THOME DIRECTOR 2.00 X 0 0 0 CARLOS PAYA DIRECTOR 2.00 X 0 0 0 CARSTEN BRUNN DIRECTOR 2.00 X 0 0 0 CEDRIC FRANCOIS DIRECTOR 2.00 X 0 0 0 CHARL VAN ZYL DIRECTOR 2.00 X 0 0 0 CHRIS STANDLEE DIRECTOR 2.00 X 0 0 0 CHRISTI SHAW DIRECTOR 2.00 X 0 0 0 CHRISTOPHE SCHILLING DIRECTOR 2.00 X 0 0 0 CHRISTOPHER HEALEY DIRECTOR 2.00 X 0 0 0 CLIVE MEANWELL DIRECTOR 2.00 X 0 0 0 DAN MEAGHER DIRECTOR 2.00 X 0 0 0 DAPHNE PREUSS DIRECTOR 2.00 X 0 0 0 DAVID KETTNER DIRECTOR 2.00 X 0 0 0 DAVID MAIN DIRECTOR 2.00 X 0 0 0 DAVID NICHOLSON DIRECTOR 2.00 X 0 0 0 DAVID STACK DIRECTOR 2.00 X 0 0 0 DEBORAH DUNSIRE DIRECTOR 2.00 X 0 0 0 DOUG BERVEN DIRECTOR 2.00 X 0 0 0 DOUGLAS DOERFLER DIRECTOR 2.00 X 0 0 0 EDDIE SULLIVAN DIRECTOR 2.00 X 0 0 0 ELIZABETH LEWIS DIRECTOR 2.00 X 0 0 0 ERIKA SMITH DIRECTOR 2.00 X 0 0 0 FABRICE CHOURAQUI DIRECTOR 2.00 X 0 0 0 FRANK TERHORST DIRECTOR 2.00 X 0 0 0 GARY ZIEZIULA DIRECTOR 2.00 X 0 0 0 GEORGE SCANGOS DIRECTOR 2.00 X 0 0 0 GIL VAN BOKKELEN DIRECTOR 2.00 X 0 0 0 GREGG ALTON DIRECTOR 2.00 X 0 0 0 H THOMAS WATKINS DIRECTOR 2.00 X 0 0 0 HELEN TORLEY DIRECTOR 2.00 X 0 0 0 HERVE HOPPENOT DIRECTOR 2.00 X 0 0 0 HOWARD ROBIN DIRECTOR 2.00 X 0 0 0 HUGH WELSH DIRECTOR 2.00 X 0 0 0 JAMES SAPIRSTEIN DIRECTOR 2.00 X 0 0 0 JAMES SULLIVAN DIRECTOR 2.00 X 0 0 0 JEAN-CHRISTOPHE TELLIER DIRECTOR 2.00 X 0 0 0 JEAN-JACQUES BIENAIME DIRECTOR 2.00 X 0 0 0 JEFF KINDLER DIRECTOR 2.00 X 0 0 0 JEFFREY CLELAND DIRECTOR 2.00 X 0 0 0 JEFFREY MARRAZZO DIRECTOR 2.00 X 0 0 0 JENNIFER HOLMGREN DIRECTOR 2.00 X 0 0 0 JENNIFER TAUBERT DIRECTOR 2.00 X 0 0 0 JEREMY LEVIN DIRECTOR 2.00 X 0 0 0 JERRY FLINT DIRECTOR 2.00 X 0 0 0 JILL ZULLO DIRECTOR 2.00 X 0 0 0 JIM MEYERS DIRECTOR 2.00 X 0 0 0 JOEL MARCUS DIRECTOR 2.00 X 0 0 0 JOHN CROWLEY DIRECTOR 2.00 X 0 0 0 JOHN LEPORE DIRECTOR 2.00 X 0 0 0 JOHN MELO DIRECTOR 2.00 X 0 0 0 JOHN SWART DIRECTOR 2.00 X 0 0 0 JOHN YOUNG DIRECTOR 2.00 X 0 0 0 JOSEPH LAROSA DIRECTOR 2.00 X 0 0 0 JOSHUA OFMAN DIRECTOR 2.00 X 0 0 0 JULIA OWENS DIRECTOR 2.00 X 0 0 0 JUSTIN GOVER DIRECTOR 2.00 X 0 0 0 KARSTEN TEMME DIRECTOR 2.00 X 0 0 0 KATRINE BOSLEY DIRECTOR 2.00 X 0 0 0 KENNETH MOCH DIRECTOR 2.00 X 0 0 0 KEVIN GORMAN DIRECTOR 2.00 X 0 0 0 KIRAN MAZUMDAR-SHAW DIRECTOR 2.00 X 0 0 0 LAURA BEREZIN DIRECTOR 2.00 X 0 0 0 LONNIE MOULDER DIRECTOR 2.00 X 0 0 0 MARK DROZDOWSKI DIRECTOR 2.00 X 0 0 0 MARK ENYEDY DIRECTOR 2.00 X 0 0 0 MARK JONES DIRECTOR 2.00 X 0 0 0 MARK PRUZANSKI DIRECTOR 2.00 X 0 0 0 MARK SKALETSKY DIRECTOR 2.00 X 0 0 0 MARK TRUDEAU DIRECTOR 2.00 X 0 0 0 MARTIN BABLER DIRECTOR 2.00 X 0 0 0 MAXINE GOWEN DIRECTOR 2.00 X 0 0 0 MICHAEL MORRISSEY DIRECTOR 2.00 X 0 0 0 MICHAEL NARACHI DIRECTOR 2.00 X 0 0 0 MICHAEL RAAB DIRECTOR 2.00 X 0 0 0 MICHAEL RYAN DIRECTOR 2.00 X 0 0 0 NANCY SIMONIAN DIRECTOR 2.00 X 0 0 0 NICK LESCHLY DIRECTOR 2.00 X 0 0 0 OLIVER WALKER DIRECTOR 2.00 X 0 0 0 PAIGE MAHANEY DIRECTOR 2.00 X 0 0 0 PAT GRUBER DIRECTOR 2.00 X 0 0 0 PAUL BACKMAN DIRECTOR 2.00 X 0 0 0 PAUL HASTINGS DIRECTOR 2.00 X 0 0 0 PAUL MCKENZIE DIRECTOR 2.00 X 0 0 0 PERRY STERNBERG DIRECTOR 2.00 X 0 0 0 PETER GREENLEAF DIRECTOR 2.00 X 0 0 0 PHILIP MILLER DIRECTOR 2.00 X 0 0 0 RACHEL KING DIRECTOR 2.00 X 0 0 0 RICHARD POPS DIRECTOR 2.00 X 0 0 0 RICK WINNINGHAM DIRECTOR 2.00 X 0 0 0 ROBERT WILLS DIRECTOR 2.00 X 0 0 0 ROGER WYSE DIRECTOR 2.00 X 0 0 0 RONALD STOTISH DIRECTOR 2.00 X 0 0 0 RUSSELL HERNDON DIRECTOR 2.00 X 0 0 0 SABINE LUIK DIRECTOR 2.00 X 0 0 0 SANDY MACRAE DIRECTOR 2.00 X 0 0 0 SARAH HULL DIRECTOR 2.00 X 0 0 0 SCOTT GARLAND DIRECTOR 2.00 X 0 0 0 SCOTT HOLMSTROM DIRECTOR 2.00 X 0 0 0 SCOTT KOENIG DIRECTOR 2.00 X 0 0 0 SCOTT SMITH DIRECTOR 2.00 X 0 0 0 SHAJI PROCIDA DIRECTOR 2.00 X 0 0 0 SHARON MATES DIRECTOR 2.00 X 0 0 0 SIMON WADDINGTON DIRECTOR 2.00 X 0 0 0 STEVEN MENTO DIRECTOR 2.00 X 0 0 0 STEVEN PAUL DIRECTOR 2.00 X 0 0 0 STUART ARBUCKLE DIRECTOR 2.00 X 0 0 0 SUE WASHER DIRECTOR 2.00 X 0 0 0 TAMMY LEE DIRECTOR 2.00 X 0 0 0 TED LOVE DIRECTOR 2.00 X 0 0 0 TERRIE CURRAN DIRECTOR 2.00 X 0 0 0 THOMAS WIGGANS DIRECTOR 2.00 X 0 0 0 TIMOTHY WALBERT DIRECTOR 2.00 X 0 0 0 TJERK DE RUITER DIRECTOR 2.00 X 0 0 0 VINCENT SEWALT DIRECTOR 2.00 X 0 0 0 WILLIAM FITZSIMMONS DIRECTOR 2.00 X 0 0 0 WILLIAM NEWELL DIRECTOR 2.00 X 0 0 0 JAMES GREENWOOD PRESIDENT & CHIEF EXECUTIVE OFFICER 40.00 X 2578863 0 150227 YVETTE WHITE-WIGGINS SVP & CHIEF FINANCIAL OFFICER 40.00 X 425637 0 71878 THOMAS DILENGE PRESIDENT, ADVOCACY/LAW/PUBLIC POLIC 40.00 X 707288 0 72513 JOANNE DUNCAN PRESIDENT, MEMBERSHIP & BUS OPER DIV 40.00 X 707288 0 67859 DANIEL DURHAM EVP, HEALTH POLICY 40.00 X 602454 0 70268 BRENT ERICKSON EVP, INDUSTRIAL & ENVIRONMENT 40.00 X 517982 0 56118 JOSEPH DAMOND SVP, INTERNATIONAL AFFAIRS 40.00 X 486197 0 73068 JEANNE HAGGERTY EVP, GOVERMENT AFFAIRS & EXTERNAL RELATIONS 40.00 X 481261 0 46953 ELIZABETH ESHAM EVP, ECS & VP, SCIENCE & REGULATORY 40.00 X 461023 0 51784 6967993 0 660668 99 0 1 0 FREEMAN EXPOSITIONS PO BOX 660613 DALLAS TX 75266 CONVENTION & CONFERENCES CONTRACTOR 2774625 LEVY RESTAURANTS FOOD SERVICE 415 SUMMER STREET BOSTON MA 02210 CATERING 1250718 PROJECTION INC PO BOX 890472 CHARLOTTE NC 28289 AUDIO/VISUAL SERVICES 966373 MASSACHUSETTS CONVENTION CENTER 415 SUMMER STREET BOSTON MA 02210 CONVENTION CENTER RENTAL 766252 SUBJECT MATTER 1201 NEW YORK AVENUE NW WASHINGTON DC 20005 CONSULTING SERVICES 751644 101 CONFERENCE/MEETING REVENUE 541800 41064421 40862634 201787 MEMBERSHIP DUES 900099 29904703 29904703 EPF MEMBER SUPPORT 900099 832500 832500 INTERNATIONAL EFFORTS 900099 506000 506000 LEGAL & POLICY SUPPORT 900099 405438 405438 135000 135000 72848062 2539768 2539768 11760723 471221 11289502 43572 43572 0 116262 117228 -966 -966 -966 CBI 900099 106428 106428 BIONEWS ADS INCOME 541800 20000 20000 36416 36416 162844 87310431 72752703 693008 13864720 X 2589000 37800 4781554 25076505 2143270 3307030 1558841 200471 69762 3730312 53443 9391095 384564 761242 1505528 4074370 1978810 17046500 7936 4764357 493483 126371 DUES & SUBSCRIPTIONS 1312273 OUTREACH 498580 TAXES PAID 374369 BIO LEGISLATIVE DAY/FLY 211040 45995 86524501 6917248 6430187 3265043 3364536 3137266 4302636 2686112 2635707 7486361 6397443 942377 1088918 64077099 61118069 81025145 78940053 17217909 18759698 13458572 15113063 3692117 3095895 34368598 36968656 X 46656547 41971397 46656547 41971397 81025145 78940053 X 785930 -6130430 659350 X 0 1 X 1 0 0 0 1 29904703 9870000 261880 10131880 9868552 263328 6252875 5778492 474383 276745 149307 127438 956741 469644 487097 1088918 CAPITAL LEASE OBLIGATION 130657 DEFERRED RENT 2965238 3095895 84120824 -6130430 2950694 -3179736 87300560 53443 -43572 9871 87310431 88805974 2374916 2374916 86431058 53443 40000 93443 86524501 PART XI, LINE 2D - OTHER ADJUSTMENTS: BIOSIMILARS REVENUE 119,103. FGR SPECIAL INITIATIVES REVENUE 392,198. CBI LOBBYING FUND 2,439,393. PART XI, LINE 4B - OTHER ADJUSTMENTS: RENTAL EXPENSES -43,572. PART XII, LINE 2D - OTHER ADJUSTMENTS: FOOD & AG LEGAL FUND EXPENSES BIOSIMILAR EXPENSES 119,103. FGR SPECIAL INITIATIVE EXPENSES 401,848. FOOD & AG SGR FUND 1,810,393. RENTAL EXPENSES 43,572. PART XII, LINE 4B - OTHER ADJUSTMENTS: DEFERRED SPONSORSHIP EXPENSE 40,000. 1 EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, 0 3 PROGRAM SERVICES CONFERENCES, ADVOCACY 569391 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 2 PROGRAM SERVICES CONFERENCES, ADVOCACY AND EDUCATION 250915 MIDDLE EAST AND NORTH AFRICA - ALGERIA, BAHRAIN, DJIBOUTI, EGYPT, 0 1 PROGRAM SERVICES ADVOCACY 7169 NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES 1 2 PROGRAM SERVICES CONFERENCES, ADVOCACY 1041159 SOUTH AMERICA - ARGENTINA, BOLIVIA, BRAZIL, CHILE, COLUMBIA, ECUADOR, 0 1 PROGRAM SERVICES ADVOCACY 107554 SOUTH ASIA - AFGHANISTAN, BANGLADESH, BHUTAN, INDIA, MALDIVES, NEPAL, 0 0 PROGRAM SERVICES ADVOCACY 9959 SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES ADVOCACY 33817 1 9 0 0 1 9 2019964 0 2019964 SOUTH AMERICA SPONSORSHIP 25000 SOUTH AMERICA DONATION 12800 2 0 0 0 0 0 0 PART I, LINE 2: THE ORGANIZATION HAS SUPPORTING DOCUMENTATION FOR THE AMOUNT THAT IS INVOICED FROM THE COMPANIES. 1 ADAP ADVOCACY ASSOCIATION 131 E DAVIE STREET SUITE 201 RALEIGH NC 27601 260482120 501(C)(3) 6000 SCHOLARSHIP AKIN GUMP STRAUSS HAUER & FELD LLP 1700 PACIFIC AVENUE SUITE 4100 DALLAS TX 752014624 751338644 N/A 15000 CONTRIBUTION ALLIANCE FOR AGING RESEARCH 1700 K STREET NW SUITE 740 WASHINGTON DC 20006 541379174 501(C)(3) 15000 SPONSORSHIP ALLIANCE TO PROTECT MEDICAL INNOVATION 1220 L ST NW SUITE 100 488 WASHINGTON DC 20005 831354631 N/A 100000 CONTRIBUTION AMERICAN AUTOIMMUNE RELATED DISEASES ASSOCIATION 22100 GRATIOT AVE EASTPOINTE MI 480212227 383027574 501(C)(3) 10000 GENERAL SUPPORT AMERICAN CANCER SOCIETY ACTION NETWORK INC 555 11TH STREET NW SUITE 300 WASHINGTON DC 20004 522340031 501(C)(4) 10000 SPONSORSHIP AMERICAN ENTERPRISE INSTITUTE FOR PUBLIC POLICY RESEARCH 1789 MASSACHUSETTS AVENUE NW WASHINGTON DC 20036 530218495 501(C)(3) 15000 GENERAL SUPPORT ARIZONA BIOINDUSTRY ASSOCIATION INC 107 S SOUTHGATE DRIVE CHANDLER AZ 85226 860938465 501(C)(6) 15000 SPONSORSHIP BIO NEBRASKA LIFE SCIENCES ASSOCIATION PO BOX 24802 OMAHA NE 68124 202214508 N/A 12000 SPONSORSHIP BIO NJ 1255 WHITEHORSE-MERCERVILLE RD BUILDING B - SUITE 514 TRENTON NJ 08619 223284393 N/A 10000 GENERAL SUPPORT BIO NJ 1255 WHITEHORSE-MERCERVILLE RD BUILDING B - SUITE 514 TRENTON NJ 08619 223284393 N/A 60000 SPONSORSHIP BIOFLORIDA INC 6742 FOREST HILL BLVD SUITE 256 WEST PALM BEACH FL 33413 593436638 501(C)(6) 5500 SPONSORSHIP BIOOHIO 1275 KINNEAR RD COLUMBUS OH 43212 341577705 501(C)(3) 12000 SPONSORSHIP BIOUTAH PO BOX 58531 SALT LAKE CITY UT 841580531 900899204 501(C)(6) 15000 GENERAL SUPPORT CANCER SUPPORT COMMUNITY 734 15TH STREET NW SUITE 300 WASHINGTON DC 20005 954163931 501(C)(3) 20000 GENERAL SUPPORT CENTER FOR MEDICINE IN THE PUBLIC INTEREST 757 THIRD AVENUE 20TH FLOOR NEW YORK NY 10017 204321812 501(C)(3) 25000 GENERAL SUPPORT CHAMBER OF COMMERCE OF THE USA 1615 H STREET NW WASHINGTON DC 20062 530045720 501(C)(6) 180000 GENERAL SUPPORT COLORADO BIOSCIENCE ASSOCIATION 600 GRANT STREET SUITE 306 DENVER CO 80203 841363258 501(C)(6) 10000 SPONSORSHIP CROPLIFE AMERICA 1156 15TH ATREET NW SUITE 400 WASHINGTON DC 20005 530190293 501(C)(6) 10000 SPONSORSHIP CULTIVATING CHANGE FOUNDATION 965 GEARY ST 2 SAN FRANCISCO CA 94109 810991258 501(C)(3) 5000 SPONSORSHIP CYSTIC FIBROSIS FOUNDATION 4550 MONTGOMERY AVENUE SUITE 1100 BETHESDA MD 20814 131930701 501(C)(3) 6500 SPONSORSHIP DEMOCRATIC GOVERNORS ASSOCIATION 1225 EYE ST NW SUITE 1100 WASHINGTON DC 20005 521304889 N/A 25000 CONTRIBUTION EVERYLIFE FOUNDATION FOR RARE DISEASES 1012 14TH ST NW SUITE 500 WASHINGTON DC 20005 264614274 501(C)(3) 10000 SPONSORSHIP FARMERS ALLIANCE FOR INTEGRATED RESOURCES 1260 COUNTY ROAD 20 1/2 LONGMONT CO 80504 454591729 501(C)(5) 25000 GENERAL SUPPORT FUELSAMERICA 607 FORT WILLIAMS PKWY ALEXANDRIA VA 22304 460991009 501(C)(4) 250000 GENERAL SUPPORT GENETIC ALLIANCE 4301 CONNECTICUT AVENUE NW SUITE 404 WASHINGTON DC 200082304 521571905 501(C)(3) 10000 GENERAL SUPPORT GEORGE MASON UNIVERSITY FOUNDATION INC 4400 UNIVERSITY DRIVE MSN 1A3 FAIRFAX VA 22201 541603842 501(C)(3) 25000 DONATION GLOBAL GENES 28 ARGONAUT SUITE 150 ALISO VIEJO CA 92656 263331487 501(C)(3) 15000 SPONSORSHIP HAWAII CROP IMPROVEMENT ASSOCIATION PO BOX 126 AIEA HI 96701 990258882 501(C)(6) 574000 GENERAL SUPPORT HAWAII FARM BUREAU FEDERATION PO BOX 253 KUNIA HI 96759 990073460 501(C)(5) 10000 GENERAL SUPPORT HAWAII LODGING & TOURISM ASSOCIATION 2270 KALAKAUA AVE SUITE 1702 HONOLULU HI 96815 990078248 501(C)(6) 20000 GENERAL SUPPORT HEALTHYWOMEN 1 HARDING RD SUITE 101 PO BOX 430 RED BANK NJ 07701 521624846 501(C)(3) 10000 SPONSORSHIP HUDSON INSTITUTE INC 1201 PENNSYLVANIA AVE NW SUITE 400 WASHINGTON DC 20004 131945157 501(C)(3) 85000 GENERAL SUPPORT INSTITUTE FOR PATIENT ACCESS PO BOX 670 BETTENDORF IA 52722 453456087 501(C)(3) 30000 DONATION IOWA BIOTECHNOLOGY ASSOCIATION 900 E DES MOINES ST DES MOINES IA 50309 319885797 501(C)(6) 10000 GENERAL SUPPORT JDRF INTERNATIONAL 26 BROADWAY 15TH FLOOR NEW YORK NY 10004 231907729 501(C)(3) 10000 SPONSORSHIP KEYSTONE POLICY CENTER 1628 SAINTS JOHN ROAD KEYSTONE CO 80435 840688506 501(C)(3) 20000 SPONSORSHIP LIFE SCIENCE TENNESSEE 217 5TH AVE NORTH SUITE 200 NASHVILLE TN 37219 621776913 501(C)(6) 28500 SPONSORSHIP LIFE SCIENCES PENNSYLVANIA 650 EAST SWEDESFORD RD SUITE 190 WAYNE PA 19087 251621500 501(C)(6) 10000 SPONSORSHIP MARYLAND TECHNOLOGY COUNCIL INC 9841 WASHINGTONIAN BLVD SUITE 200 GAITHERSBURG MD 20878 204950778 501(C)(6) 20000 GENERAL SUPPORT MARYLAND TECHNOLOGY COUNCIL INC 9841 WASHINGTONIAN BLVD SUITE 200 GAITHERSBURG MD 20878 204950778 501(C)(6) 7500 SPONSORSHIP MEDMATES INC 184 BURNSIDE AVENUE WOONSOCKET RI 02895 462858053 501(C)(6) 6000 SPONSORSHIP NATIONAL COALITION FOR CANCER SURVIVORSHIP 8455 COLESVILLE ROAD SUITE 930 SILVER SPRING MD 20910 850357897 501(C)(3) 20000 SPONSORSHIP NATIONAL FARMERS UNION 20 F STREET NW SUITE300 WASHINGTON DC 20001 840200555 501(C)(3) 10000 SPONSORSHIP NATIONAL PSORIASIS FOUNDATION 6600 SW 92ND AVE SUITE 300 PORTLAND OR 97223 930571472 501(C)(3) 15000 GENERAL SUPPORT NEHI INC 133 FEDERAL STREET 9TH FLOOR BOSTON MA 02110 010624865 501(C)(3) 25000 GENERAL SUPPORT NEHI INC 133 FEDERAL STREET 9TH FLOOR BOSTON MA 02110 010624865 501(C)(3) 25000 GENERAL SUPPORT NO LABELS 1130 CONNECTICUT AVE NW SUITE 325 WASHINGTON DC 20036 271432208 501(C)(4) 15000 CONTRIBUTION OREGON BIOSCIENCE ASSOCIATION 2828 SW CORBETT AVE SUITE 115 PORTLAND OR 97201 931009329 501(C)(5) 10000 SPONSORSHIP PARTNERSHIP FOR AMERICA'S HEALTH CARE FUTURE INC PO BOX 65492 WASHINGTON DC 200355492 830939222 N/A 300000 DONATION PERSONALIZED MEDICINE COALITION 1710 RHODE ISLAND AVE NW WASHINGTON DC 20036 542134884 501(C)(3) 10000 SPONSORSHIP PHRMA 950 F STREET NW SUITE 300 WASHINGTON DC 20004 530241211 501(C)(6) 40000 SPONSORSHIP PREVENT CANCER FOUNDATION 1600 DUKE STREET SUITE 500 ALEXANDRIA VA 22314 521429544 501(C)(3) 7000 SPONSORSHIP REPUBLICAN GOVERNORS ASSOCIATION 1747 PENNSYLVANIA AVE NW SUITE 250 WASHINGTON DC 20006 113655877 N/A 100000 GENERAL SUPPORT SOCIETY FOR WOMEN'S HEALTH RESEARCH 1025 CONNECTICUT AVE NW SUITE 601 WASHINGTON DC 20036 521694732 501(C)(3) 15000 SPONSORSHIP TEXAS HEALTHCARE AND BIOSCIENCE INSTITUTE 815 BRAZOS ST SUITE 310 AUSTIN TX 78701 760501034 501(C)(6) 25000 GENERAL SUPPORT THE CONGRESSIONAL HUNGER CENTER WEWORK APOLLO BUILDING 810 7TH ST NE SUITE 02-146 WASHINGTON DC 20002 521842738 501(C)(3) 5000 SPONSORSHIP THE GALIEN FOUNDATION INC 99 JOHN STREET SUITE 2502 NEW YORK NY 10038 264549935 501(C)(3) 15000 SPONSORSHIP THE LEUKEMIA & LYMPHOMA SOCIETY NATIONAL CAPITAL AREA CHAPTER 3601 EISENHOWER AVENUE SUITE 450 ALEXANDRIA VA 22304 135644916 501(C)(3) 10000 SPONSORSHIP THE UNITED STATES ASSOCIATION OF FORMER MEMBERS OF CONGRESS 1401 K STREET NW SUITE 503 WASHINGTON DC 20005 540883744 501(C)(3) 25000 SPONSORSHIP THORN RUN PARTNERS LLC 100 M STREET SE SUITE 750 WASHINGTON DC 20003 271541515 N/A 140000 GENERAL SUPPORT WASHINGTON INTERNATIONAL TRADE FOUNDATION 1300 PENNSYLVANIA AVE NW SUITE 400 WASHINGTON DC 20004 521907420 501(C)(3) 9000 CONTRIBUTION WASHINGTON LEGAL FOUNDATION 2009 MASSACHUSETTS AVE NW WASHINGTON DC 20036 521071570 501(C)(3) 10000 GENERAL SUPPORT 36 43 PART I, LINE 2: BIO RELIES ON THE REQUIRED QUALIFICATIONS OF THE GRANT RECIPIENTS TO PROVIDE ASSURANCE OF PROPER USAGE. IN SOME CASES, BIO PERSONNEL ATTEND EVENTS AND RECEIVE ACKNOWLEDGEMENTS RELATED TO THE FUNDS GRANTED. X 0 1 X X X X X 0 1 0 JAMES GREENWOOD PRESIDENT & CHIEF EXECUTIVE OFFICER 1563303 0 1015560 0 0 0 36500 0 113727 0 2729090 0 0 0 YVETTE WHITE-WIGGINS SVP & CHIEF FINANCIAL OFFICER 323667 0 101970 0 0 0 36500 0 35378 0 497515 0 0 0 THOMAS DILENGE PRESIDENT, ADVOCACY/LAW/PUBLIC POLIC 484674 0 222614 0 0 0 36500 0 36013 0 779801 0 0 0 JOANNE DUNCAN PRESIDENT, MEMBERSHIP & BUS OPER DIV 484674 0 222614 0 0 0 36500 0 31359 0 775147 0 0 0 DANIEL DURHAM EVP, HEALTH POLICY 459654 0 142800 0 0 0 36500 0 33768 0 672722 0 0 0 BRENT ERICKSON EVP, INDUSTRIAL & ENVIRONMENT 398000 0 101970 0 18012 0 36500 0 19618 0 574100 0 0 0 JOSEPH DAMOND SVP, INTERNATIONAL AFFAIRS 373858 0 112339 0 0 0 36500 0 36568 0 559265 0 0 0 JEANNE HAGGERTY EVP, GOVERMENT AFFAIRS & EXTERNAL RE 350000 0 113344 0 17917 0 33794 0 13159 0 528214 0 0 0 ELIZABETH ESHAM EVP, ECS & VP, SCIENCE & REGULATORY 350000 0 111023 0 0 0 36500 0 15284 0 512807 0 0 0 PART I, LINE 1A INCLUDED IN TAXABLE COMPENSATION TO THE INDIVIDUAL -TRAVEL FOR COMPANIONS - $8,016 PART I, LINE 1B THE CHIEF EXECUTIVE OFFICER HAS A PREPAID SPENDING ACCOUNT AT A LOCAL RESTAURANT, USED EXCLUSIVELY FOR BUSINESS PURPOSES. PART I, LINE 4B JAMES GREENWOOD - 457(F) $741,468 LAURA GREENWOOD DAUGHTER OF CEO 76724 PAID EMPLOYEE OF ORGANIZATION 0 LILY DOEFLER DAUGHTER OF A BOARD MEMBER 50981 PAID EMPLOYEE OF ORGANIZATION 0 FORM 990, PART VI, SECTION A, LINE 1 THE BOARD OF DIRECTORS SHALL DESIGNATE BY RESOLUTION AND WITH A QUORUM PRESENT, NOT MORE THAN NINETEEN (19) DIRECTORS OF THE BOARD TO ACT AS AN EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE SHALL CONSIST OF THE SEVEN (7) ELECTED OFFICERS OF THE ORGANIZATION; THE IMMEDIATE PAST CHAIR OF THE ORGANIZATION; THE VICE CHAIRS OF EACH SECTION'S GOVERNING BOARD; AND THE BALANCE BEING AT-LARGE DIRECTORS FROM THE FULL BOARD. IF THE IMMEDIATE PAST CHAIR IS NO LONGER ELIGIBLE TO SERVE ON THE FULL BOARD, AN ADDITIONAL AT-LARGE DIRECTOR FROM THE FULL BOARD SHALL BE SELECTED FOR THE EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE SHALL HAVE, AND BE AUTHORIZED TO EXERCISE, ALL POWERS OF THE FULL BOARD, EXCEPT: (A) THE POWER TO ELECT OR REMOVE ELECTED OFFICERS OR DIRECTORS, TO CHANGE THE SIZE OF THE BOARD, TO CHANGE ELIGIBILITY, QUALIFICATIONS OR RIGHTS OF MEMBERSHIP, OR TO MAKE DETERMINATIONS AS TO DIRECTOR AND OFFICER COMPENSATION, WHERE APPLICABLE; AND (B) THE POWER TO AMEND THE ARTICLES OF INCORPORATION OR THE BYLAWS OF THE ORGANIZATION. FORM 990, PART VI, SECTION A, LINE 6 THE MEMBERS OF THE ORGANIZATION SHALL BE DIVIDED INTO FOUR CLASSES; CORE MEMBERS, ASSOCIATE MEMBERS, AFFILIATE MEMBERS, AND CENTER MEMBERS, DEFINED AS FOLLOWS: (A) CORE MEMBERS: ANY CORPORATION, PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY ORGANIZED FOR PROFIT, A SUBSTANTIAL PERCENTAGE OF WHOSE BUSINESS ACTIVITIES INVOLVE BIOTECHNOLOGY, GENOMICS, BIOINFORMATICS OR RELATED NEW TECHNOLOGIES, IS ELIGIBLE FOR MEMBERSHIP. CORE MEMBERS ARE THOSE ENTITIES THAT UTILIZE BIOTECHNOLOGY, GENOMICS, BIOINFORMATICS OR OTHER RELATED NEW TECHNOLOGIES IN RESEARCH, DEVELOPMENT, TESTING, MANUFACTURING, OR SALES OF PRODUCT OR INFORMATION, AS WELL AS OTHER FIRMS THE BOARD SO CHARACTERIZES AND PLACES IN THIS CATEGORY. CORE MEMBERS SHALL BE GROUPED IN THE FOLLOWING SUBCATEGORIES: (I) EMERGING COMPANIES, WHICH ARE FIRMS THAT EMPLOY LESS THAN 350 PERSONS AND THAT DO NOT HAVE A THERAPEUTIC OR DIAGNOSTIC PRODUCT APPROVED FOR SALE IN THE U.S. MARKET; (II) ESTABLISHED FIRMS, WHICH ARE THOSE FIRMS THAT EMPLOY 350 OR MORE PERSONS OR THAT HAVE A THERAPEUTIC OR DIAGNOSTIC PRODUCT APPROVED FOR SALE IN THE U.S. MARKET; AND (III) LARGE FIRMS, WHICH ARE ESTABLISHED FIRMS THAT HAVE ANNUAL WORLDWIDE SALES OF BIOTECHNOLOGY PRODUCTS IN EXCESS OF $1.5 BILLION; AND (IV) NON-DOMESTIC COMPANIES, WHICH ARE CORE MEMBERS WITHOUT SIGNIFICANT OPERATIONS IN THE UNITED STATES OR SIGNIFICANT COLLABORATIONS WITH A U.S. ENTITY. (B) ASSOCIATE MEMBERS: ANY CORPORATION, PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY ORGANIZED FOR PROFIT, A SUBSTANTIAL PORTION OF WHOSE ACTIVITIES INVOLVE PROVIDING SERVICES OR PRODUCTS OF BENEFIT TO COMPANIES WHOSE PRINCIPAL BUSINESS IS BIOTECHNOLOGY, IS ELIGIBLE FOR ASSOCIATE MEMBERSHIP. ASSOCIATE MEMBERS ARE THOSE COMMERCIAL ENTITIES WHICH DO NOT NECESSARILY UTILIZE BIOTECHNOLOGY; E.G. TECHNICAL SUPPORT, EQUIPMENT, CONSTRUCTION, ACCOUNTING, AND LAW FIRMS THAT SERVICE THE BIOTECHNOLOGY INDUSTRY, AS WELL AS OTHER FIRMS THAT THE BOARD CHARACTERIZES AND PLACES IN THIS CATEGORY. (C) AFFILIATE MEMBERS: ANY GOVERNMENTAL OR NONPROFIT ENTITY OR COUNTRY, STATE OR REGIONAL INDUSTRY, TRADE OR PROFESSIONAL ASSOCIATION WITH AN INTEREST IN, OR A MANDATE TO PROMOTE THE DEVELOPMENT OF, BIOTECHNOLOGY IS ELIGIBLE FOR AFFILIATE MEMBERSHIP. THERE SHALL BE NO SIZE TESTS APPLIED TO AFFILIATE MEMBER APPLICANTS. (D) CENTER MEMBERS: ANY INSTITUTION, NOT GENERALLY ELIGIBLE FOR CORE MEMBERSHIP THAT IS SPONSORED BY A STATE, REGION, OR ACADEMIC INSTITUTION AND WORKS IN SUPPORT OF COMMERCIAL BIOTECHNOLOGY MAY BE ELIGIBLE FOR CONSIDERATION AS A CENTER MEMBER. FORM 990, PART VI, SECTION A, LINE 7A AT ALL MEMBERSHIP MEETINGS OF THE ORGANIZATION, EACH CURRENT MEMBER SHALL HAVE ONE (1) VOTE AND MAY TAKE PART IN THE VOTING IN PERSON OR BY PROXY. FOR EACH SECTION IN WHICH THE MEMBER PARTICIPATES, EACH MEMBER SHALL HAVE THE RIGHT TO VOTE ON THE ELECTION OF DIRECTORS FOR THE SECTION GOVERNING BOARD, BUT SHALL HAVE NO OTHER VOTING RIGHTS EXCEPT ON MATTERS BROUGHT TO THE MEMBERSHIP BY ANY SUCH GOVERNING BOARD OR THE ORGANIZATION'S BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 AND RELATED SCHEDULES ARE PREPARED BY THE ORGANIZATION'S CERTIFIED PUBLIC ACCOUNTANTS UNDER THE GUIDANCE OF THE CHIEF FINANCIAL OFFICER (CFO). THE CFO AND THE CONTROLLER THOROUGHLY REVIEW ALL CALCULATIONS AND SCHEDULES TO CONFIRM THEY REFLECT THE ACTUAL FINANCIAL RESULTS OF THE ORGANIZATION. THE COMPLETE FORM 990 IS THEN REVIEWED INTERNALLY BY THE CEO, DIVISION PRESIDENTS, CFO, AND CONTROLLER IN CONSULTATION WITH LEGAL COUNSEL AND, AS APPROPRIATE, FURTHER CONSULTATION WITH THE ORGANIZATION'S CERTIFIED PUBLIC ACCOUNTANTS. FINALLY, THE FORM 990 IS PROVIDED TO THE CHAIRMAN OF THE BOARD AND BIO EXECUTIVE COMMITTEE MEMBERS FOR THEIR REVIEW, QUESTIONS AND/OR COMMENTS. ALL REVIEWS ARE COMPLETED BEFORE THE FORM IS FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) TAKES SEVERAL STEPS TO ADDRESS COMPLIANCE BY EMPLOYEES AND DIRECTORS WITH ITS CONFLICTS OF INTEREST POLICY. BIO TRAINS ALL NEW EMPLOYEES AND DIRECTORS ON VARIOUS ASPECTS OF BIO'S COMPLIANCE PROGRAM, INCLUDING CONFLICTS OF INTEREST, AND BIO'S WRITTEN CONFLICTS OF INTEREST POLICY REQUIRES ALL EMPLOYEES TO DISCLOSE ANY OUTSIDE PERSONAL BUSINESS INTERESTS TO THEIR SUPERVISOR. BIO'S GENERAL COUNSEL REGULARLY ADVISES BIO'S EXECUTIVES AND SUPERVISORS ON SUCH MATTERS. BIO ALSO CONTRACTS WITH AN INDEPENDENT ORGANIZATION TO PROVIDE EMPLOYEES AND OTHERS WITH THE ABILITY TO FILE ANONYMOUS REPORTS CONCERNING THE VIOLATION OF ANY LAWS OR BIO POLICIES, INCLUDING ALLEGATIONS OF POTENTIAL CONFLICTS OF INTEREST, AND BIO HAS A PROCESS IN PLACE TO FOLLOW UP ON ANY SUCH COMPLAINTS IN A TIMELY AND THOROUGH MANNER. FURTHER, BIO UNDERTAKES A QUESTIONNAIRE SENT TO EACH DIRECTOR ON ITS BOARD OF DIRECTORS SEEKING DISCLOSURE OF ANY POTENTIAL CONFLICTS OF INTERESTS THEY MAY HAVE, OR THEIR FAMILY MEMBERS MAY HAVE, ASSOCIATED WITH BUSINESSES OR ORGANIZATIONS THAT DO BUSINESS WITH BIO. POTENTIAL CONFLICTS ARE MONITORED AND REVIEWED AT THE MANAGEMENT AND SENIOR MANAGEMENT LEVEL OF THE ORGANIZATION, AND DEPENDING ON THE CONFLICT, DETERMINATIONS MAY BE MADE AT THE BOARD OR SENIOR MANAGEMENT LEVEL. A CONFLICT AT THE BOARD LEVEL WILL NORMALLY RESULT IN RECUSAL OF THE INDIVIDUAL FROM PARTICIPATION OR ACTIVITIES WITH RESPECT TO THE RELEVANT SUBJECT MATTER. AT THE STAFF LEVEL, THE APPLICABLE BIO SUPERVISOR IS INFORMED OF THE POTENTIAL CONFLICT AND IS REQUIRED TO TAKE ALL APPROPRIATE STEPS TO ENSURE THAT THE INDIVIDUAL DOES NOT PARTICIPATE IN, OR RECEIVE CONFIDENTIAL INFORMATION RELATING TO, ANY BIO ACTIVITY RELATED TO THE SUBJECT MATTER OF THE CONFLICT, UP TO AND INCLUDING, WHERE APPROPRIATE, TERMINATION OF SUCH EMPLOYEE. FORM 990, PART VI, SECTION B, LINE 15 FOR 2018, THE PRESIDENT AND CHIEF EXECUTIVE OFFICER (CEO) OF BIO WAS COMPENSATED PER THE TERMS OF A MULTI-YEAR CONTRACT THAT WAS DETERMINED WITH INDEPENDENT REVIEW, COMPARABILITY DATA, AND CONTEMPORANEOUS SUBSTANTIATION OF THE DELIBERATION AND DECISION AS INDICATED IN PRIOR FORM 990 SUBMISSIONS. IN ADDITION, BASED ON THE EXECUTIVE COMMITTEE'S EVALUATION OF THE PRESIDENT AND CEO'S PERFORMANCE FOR 2018, THE COMMITTEE DETERMINED THE APPROPRIATE AMOUNT FOR THE DISCRETIONARY COMPONENT OF HIS COMPENSATION FOR THAT YEAR, IN ACCORDANCE WITH THE RELEVANT PROVISION OF THE EXECUTIVE AGREEMENT. DECISIONS REGARDING THE COMPENSATION FOR OFFICERS AND KEY EMPLOYEES OF THE ORGANIZATION ARE NEGOTIATED INDIVIDUALLY AND ARE PERFORMANCE-BASED, IN ACCORDANCE WITH AN ANNUAL WRITTEN EVALUATION PROCESS THAT HAS BEEN ESTABLISHED FOR ALL EMPLOYEES OF THE ORGANIZATION. THE PRESIDENTS OF THE TWO DIVISIONS AT BIO LED THE PROCESS, IN COORDINATION WITH THE PRESIDENT & CEO. AN INDEPENDENT CONSULTANT PROVIDES COMPARATIVE BENCHMARKING SERVICES FOR SENIOR MANAGEMENT POSITIONS, AND OTHER INFORMATION ON COMPENSATION ISSUES, TRENDS, POLICIES, AND BEST PRACTICES FOR USE BY THE ORGANIZATION. THE ORGANIZATION ALSO HAS AN ESTABLISHED COMPENSATION POLICY FOR ALL OF ITS EMPLOYEES, WHICH SETS FORTH THE GENERAL PARAMETERS GOVERNING BIO'S COMPENSATION PRACTICES. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC. FORM 990, PART IX, LINE 11G EC EMERGING PRIORITIES 6,859,539. WORKPLAN OBJECTIVES 79,775. I&E INITIATIVES 35,242. INTERNS 45,728. TEMPORARY HELP 159,530. CEO DELEGATION EXPENSE 17,187. ECONOMIC STUDIES 360,174. CONSULTANTS AND OTHER PROFESSIONAL FEES 1,493,584. BIO-PAC ADMINISTRATIVE 27,437. BUSINESS DEVELOPMENT EXEC PRESENTATION 43,875. PROGRAM INITIATIVES 66,388. RECRUITMENT 125,069. BUSINESS STRATEGIES 9,613. EDUCATION 67,954. FORM 990, PART XI, LINE 9: DEFERRED SPONSORSHIP EXPENSE 40,000. NET EXCLUSIVE BUSINESS SOLUTION 619,350. EXCELLENCE THROUGH STEWARDSHIP 1201 MARYLAND AVE SW SUITE 900 WASHINGTON DC 20024 263021330 TO PROMOTE THE RESPONSIBLE USE OF AGRICULTURAL BIOTECHNOLOGY DC 501(C)(4) 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0